openPR Logo
Press release

Drug Eluting Balloon Catheter Market is Expected to Grow at a Massive CAGR of over 18.3% by 2022

08-23-2017 08:03 AM CET | Health & Medicine

Press release from: Fact.MR

Drug Eluting Balloon Catheter Market is Expected to Grow at

Drug eluting balloon catheter is witnessing robust adoption owing to its overwhelming results in cardiovascular and peripheral artery procedures. Moreover, drug eluting balloon catheter is also turning out to be useful for patients who are unable to undergo percutaneous coronary intervention (PCI) procedures. Encouraged by this situation, various drug eluting balloon catheter manufacturers across the globe are now increasing their production capacity. The aforementioned factors are reflecting favourably on the global sales of the drug eluting balloon catheter. Also, companies are aiming to manufacture cost-effective catheters that in order to increase market penetration. Growing prevalence of cardiovascular diseases and soaring incidences of cardiology intervention procedures is facilitating the growth of the global drug eluting balloon catheter market. Fact.MR projects that the global market for drug eluting balloon catheter will surge at a robust CAGR between 2018 and 2022. In addition, factors such as enhanced reimbursement policies, rising geriatric population and growing healthcare expenditure are anticipated to positively impact the market’s growth. The arrival of new-generation drug eluting balloon catheters as well as heavier investments in R&D pipelines in order to increase its utility is also anticipate to create lucrative growth opportunities for manufacturers and stakeholder in the global market for drug eluting balloon catheter.

Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=146

Key Insights From the Report Include:

Among regions, Europe will retain its dominant position in the market over the forecast period. Between 2017 and 2022, the drug eluting balloon catheter market in Europe will reflect a CAGR of 20.5%. Meanwhile, the Asia-Pacific excluding Japan (APEJ) market will also witness a robust growth over the next couple of years.

By indication, drug eluting balloon catheter will be used mostly for treating coronary artery disease. Currently, coronary artery disease indication segment will command for more than two-third revenue share of the global market.

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=146

Hospitals will remain the largest end user of drug eluting balloon catheter in 2017 and 2022. Sales of drug eluting balloon catheter currently commands for close to 73% market share in terms of revenue. Hospitals are one of the most preferred medical settings for undertaking coronary artery and restenosis procedures.

By raw material, demand nylon based drug eluting balloon catheter will continue to gain traction over the assessment period. Currently, sales of nylon based drug eluting balloon catheter account for close to 54.1% revenue share of the global market. Towards to the end of 2022, more than US$ 244 Mn worth nylon drug eluting balloon catheters are expected to be sold worldwide.
Competition Tracking

Fact.MR’s report has also mentioned some of the key players functioning in the global market for drug eluting balloon catheter, which include Medtronic Plc., Cook Medical INC, Abbott Laboratories, Jotech GmbH, Terumo Corporation, Tokai Medical Products Inc., B. Braun Melsungen AG, Cardionovum GmbH, Cordis Corporation, Meril Life Sciences Pvt Ltd, MicroPort Scientific Corporation, Boston Scientific Corporation, and BIOTRONIK SE & Co. KG

Click to View Complete Report @ https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market

About Us

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

Office: Dublin 2

Suite 9884

27 Upper Pembroke Street,

Dublin 2, Ireland

Tel: +353-1-6111-593

( Dublin 2 )

Email: sales@factmr.com

Web: https://www.factmr.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Eluting Balloon Catheter Market is Expected to Grow at a Massive CAGR of over 18.3% by 2022 here

News-ID: 680541 • Views:

More Releases from Fact.MR

Body Area Network Market Forecasted to Expand Rapidly, Projecting US$ 229.8 Billion Value by 2032
Body Area Network Market Forecasted to Expand Rapidly, Projecting US$ 229.8 Bill …
It is anticipated that the worldwide body area network market will expand at a strong 22.3% CAGR. Its anticipated value increased from US$ 24.6 billion in 2021 to around US$ 229.8 billion by 2032. A new generation of body-attachable wireless body sensors has emerged in response to advancements in wireless communication technology and various physiological sensor types. Download a Sample Copy Of Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7208 Body Area Networks, or BANs, are becoming a game-changer
Payroll Outsourcing Services Market Is Likely To Be Valued At US$ 32607.5 Million By 2033: Fact.MR Report
Payroll Outsourcing Services Market Is Likely To Be Valued At US$ 32607.5 Millio …
The global payroll outsourcing services market was valued at US$ 17000 Million in 2022. During the 2023-2033 period of assessment, demand is expected to rise at a 6.1% value CAGR, likely to surpass a valuation of US$ 32607.5 Million by the end of the said forecast period. The Payroll Outsourcing Services Industry sales study offers a comprehensive analysis on diverse features including production capacities, Payroll Outsourcing Services demand, product developments, sales
Carotenoids Market Is Forecasted To Reach US$ 2.45 Billion at 5.4% CAGR By 2034: Fact.MR Report
Carotenoids Market Is Forecasted To Reach US$ 2.45 Billion at 5.4% CAGR By 2034: …
With an estimated market size of US$ 1.45 billion in 2024, the global carotenoid market is projected to expand at a CAGR of 5.4% and reach a market value of US$ 2.45 billion by 2034-end. Growth prospects of the market remain optimistic, owing to shifting consumer preferences for natural ingredients, expanding carotenoid applications in a range of industries, and ongoing developments in product development and formulation techniques. The Carotenoid Industry sales
Canned Fruits Market Is Anticipated To Reach A Valuation Of US$ 12 Billion By 2032: Fact.MR Report
Canned Fruits Market Is Anticipated To Reach A Valuation Of US$ 12 Billion By 20 …
The value of the global canned fruits market is US$ 9.8 billion in 2022, which is projected to climb to US$ 12 billion by 2032-end, increasing at a CAGR of 2% through 2032. The Canned Fruits Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Fruits demand, product developments, sales revenue generation and Canned Fruits market outlook across the globe. market research report by Fact.MR, (Leading business

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug